188 related articles for article (PubMed ID: 20651981)
21. Comparative study of the binding pockets of mammalian proprotein convertases and its implications for the design of specific small molecule inhibitors.
Tian S; Jianhua W
Int J Biol Sci; 2010 Feb; 6(1):89-95. PubMed ID: 20151049
[TBL] [Abstract][Full Text] [Related]
22. Novel Insights into Structure-Activity Relationships of N-Terminally Modified PACE4 Inhibitors.
Kwiatkowska A; Couture F; Levesque C; Ly K; Beauchemin S; Desjardins R; Neugebauer W; Dory YL; Day R
ChemMedChem; 2016 Feb; 11(3):289-301. PubMed ID: 26751825
[TBL] [Abstract][Full Text] [Related]
23. Positional Scanning Identifies the Molecular Determinants of a High Affinity Multi-Leucine Inhibitor for Furin and PACE4.
Małuch I; Levesque C; Kwiatkowska A; Couture F; Ly K; Desjardins R; Neugebauer WA; Prahl A; Day R
J Med Chem; 2017 Apr; 60(7):2732-2744. PubMed ID: 28287731
[TBL] [Abstract][Full Text] [Related]
24. Implications of Proprotein Convertases in Ovarian Cancer Cell Proliferation and Tumor Progression: Insights for PACE4 as a Therapeutic Target.
Longuespée R; Couture F; Levesque C; Kwiatkowska A; Desjardins R; Gagnon S; Vergara D; Maffia M; Fournier I; Salzet M; Day R
Transl Oncol; 2014 May; 7(3):410-9. PubMed ID: 24818756
[TBL] [Abstract][Full Text] [Related]
25. Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines.
Dianati V; Kwiatkowska A; Couture F; Desjardins R; Dory YL; Day R
J Med Chem; 2018 Sep; 61(18):8457-8467. PubMed ID: 30180568
[TBL] [Abstract][Full Text] [Related]
26. Subtilisin-like proprotein convertase PACE4 is required for skeletal muscle differentiation.
Yuasa K; Masuda T; Yoshikawa C; Nagahama M; Matsuda Y; Tsuji A
J Biochem; 2009 Sep; 146(3):407-15. PubMed ID: 19520771
[TBL] [Abstract][Full Text] [Related]
27. Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth.
Bassi DE; Zhang J; Renner C; Klein-Szanto AJ
Mol Carcinog; 2017 Mar; 56(3):1182-1188. PubMed ID: 27584082
[TBL] [Abstract][Full Text] [Related]
28. The paired basic amino acid-cleaving enzyme 4 (PACE4) is involved in the maturation of insulin receptor isoform B: an opportunity to reduce the specific insulin receptor-dependent effects of insulin-like growth factor 2 (IGF2).
Kara I; Poggi M; Bonardo B; Govers R; Landrier JF; Tian S; Leibiger I; Day R; Creemers JW; Peiretti F
J Biol Chem; 2015 Jan; 290(5):2812-21. PubMed ID: 25527501
[TBL] [Abstract][Full Text] [Related]
29. Improving the Selectivity of PACE4 Inhibitors through Modifications of the P1 Residue.
Dianati V; Navals P; Couture F; Desjardins R; Dame A; Kwiatkowska A; Day R; Dory YL
J Med Chem; 2018 Dec; 61(24):11250-11260. PubMed ID: 30501188
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of proprotein convertase, PACE4, by alpha1-antitrypsin Portland (alpha1-PDX), a blocker of proteolytic activation of bone morphogenetic protein during embryogenesis: evidence that PACE4 is able to form an SDS-stable acyl intermediate with alpha1-PDX.
Tsuji A; Hashimoto E; Ikoma T; Taniguchi T; Mori K; Nagahama M; Matsuda Y
J Biochem; 1999 Sep; 126(3):591-603. PubMed ID: 10467177
[TBL] [Abstract][Full Text] [Related]
31. Expression of PACE4 in chemically induced carcinomas is associated with spindle cell tumor conversion and increased invasive ability.
Hubbard FC; Goodrow TL; Liu SC; Brilliant MH; Basset P; Mains RE; Klein-Szanto AJ
Cancer Res; 1997 Dec; 57(23):5226-31. PubMed ID: 9393739
[TBL] [Abstract][Full Text] [Related]
32. Characterization and expression of proprotein convertases in CHO cells: Efficient proteolytic maturation of human bone morphogenetic protein-7.
Sathyamurthy M; Kim CL; Bang YL; Kim YS; Jang JW; Lee GM
Biotechnol Bioeng; 2015 Mar; 112(3):560-8. PubMed ID: 25219685
[TBL] [Abstract][Full Text] [Related]
33. Transcriptional regulation of subtilisin-like proprotein convertase PACE4 by E2F: possible role of E2F-mediated upregulation of PACE4 in tumor progression.
Yuasa K; Suzue K; Nagahama M; Matsuda Y; Tsuji A
Gene; 2007 Nov; 402(1-2):103-10. PubMed ID: 17825503
[TBL] [Abstract][Full Text] [Related]
34. Engineering of alpha1-antitrypsin variants selective for subtilisin-like proprotein convertases PACE4 and PC6: importance of the P2' residue in stable complex formation of the serpin with proprotein convertase.
Tsuji A; Kanie H; Makise H; Yuasa K; Nagahama M; Matsuda Y
Protein Eng Des Sel; 2007 Apr; 20(4):163-70. PubMed ID: 17351018
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model.
Nejjari M; Berthet V; Rigot V; Laforest S; Jacquier MF; Seidah NG; Remy L; Bruyneel E; Scoazec JY; Marvaldi J; Luis J
Am J Pathol; 2004 Jun; 164(6):1925-33. PubMed ID: 15161629
[TBL] [Abstract][Full Text] [Related]
36. PACE4 regulates proliferation, migration and invasion in human breast cancer MDA-MB-231 cells.
Wang F; Wang L; Pan J
Mol Med Rep; 2015 Jan; 11(1):698-704. PubMed ID: 25333574
[TBL] [Abstract][Full Text] [Related]
37. Proprotein convertases: "master switches" in the regulation of tumor growth and progression.
Bassi DE; Fu J; Lopez de Cicco R; Klein-Szanto AJ
Mol Carcinog; 2005 Nov; 44(3):151-61. PubMed ID: 16167351
[TBL] [Abstract][Full Text] [Related]
38. PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation.
Levesque C; Couture F; Kwiatkowska A; Desjardins R; Guérin B; Neugebauer WA; Day R
Oncotarget; 2015 Feb; 6(6):3680-93. PubMed ID: 25682874
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of PACE4 in prostate cancer is not dependent on E2F transcription factors.
Bakrania A; Aubé M; Desjardins R; Sabbagh R; Day R
Can J Physiol Pharmacol; 2020 Jul; 98(7):477-481. PubMed ID: 32119574
[TBL] [Abstract][Full Text] [Related]
40. A proteomic approach reveals transient association of reticulocalbin-3, a novel member of the CREC family, with the precursor of subtilisin-like proprotein convertase, PACE4.
Tsuji A; Kikuchi Y; Sato Y; Koide S; Yuasa K; Nagahama M; Matsuda Y
Biochem J; 2006 May; 396(1):51-9. PubMed ID: 16433634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
